Research output per year
Research output per year
Fingerprint
Dive into the research topics where Stefan Symeonides is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM)
Vasudev, N. S., Ainsworth, G., Brown, S., Pickering, L., Waddell, T., Fife, K., Griffiths, R., Sharma, A., Katona, E., Howard, H., Velikova, G., Maraveyas, A., Brown, J., Pezaro, C., Tuthill, M., Boleti, E., Bahl, A., Szabados, B., Banks, R. E., Brown, J., & 7 others, 6 Nov 2023, In: Journal of Clinical Oncology.Research output: Contribution to journal › Article › peer-review
Open Access -
Patient-reported outcomes in KEYNOTE-564: adjuvant pembrolizumab versus placebo for renal cell carcinoma
Choueiri, T. K., Tomczak, P., Park, S. H., Venugopal, B., Symeonides, S. N., Hajek, J., Ferguson, T., Chang, Y-H., Lyun Lee, J., Haas, N., Sawrycki, P., Sarwar, N., Gross-Goupil, M., Thiery-Vuillemin, A., Maheve, M., Kimura, G., F. Perini, R., L. Saretsky, T., Bhattacharya, R., Xu, L., & 1 others, 17 Aug 2023, In: The Oncologist.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
The immunopeptidome from a genomic perspective: Establishing the noncanonical landscape of MHC class I–associated peptides
Bedran, G., Gasser, H-C., Weke, K., Wang, T., Bedran, D., Laird, A., Battail, C., Zanzotto, F. M., Pesquita, C., Axelson, H., Rajan, A., Harrison, D. J., Palkowski, A., Pawlik, M., Parys, M., O'Neill, J. R., Brennan, P. M., Symeonides, S. N., Goodlett, D. R., Litchfield, K., & 4 others, 1 Jun 2023, In: Cancer Immunology Research. 11, 6, p. 747-762 39 p., 22-0621.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Project Optimus, an FDA initiative: considerations for cancer drug development internationally, from an academic perspective
Murphy, R., Halford, S. & Symeonides, S. N., 3 Mar 2023, In: Frontiers in Oncology.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
ARomatase Inhibition plus/minus Src-inhibitor SaracaTinib (AZD0530) in Advanced breast CAncer Therapy (ARISTACAT): a randomised phase II study
Oswald, A., Symeonides, S. N., Wheatley, D., Chan, S., Murray Brunt, A., McAdam, K., Schmid, P., Waters, S., Poole, C., Twelves, C., Perren, T., Bartlett, J., Piper, T., Macdonald Chisholm, E., Welsh, M., Hill, R., Hopcroft, L. E., Barrett-Lee, P. & Cameron, D. A., 2 Mar 2023, In: Breast cancer research and treatment.Research output: Contribution to journal › Article › peer-review
Open AccessFile
Projects
- 1 Finished
Press/Media
-
Dr Stefan Symeonides comments on proposed new treatments for cancer sufferers
4/03/16
7 items of Media coverage
Press/Media: Expert Comment
-
Team led by Dr Stefan Symeonides trials new treatment for pancreatic cancer
30/09/16
1 item of Media coverage
Press/Media: Research